Rett syndrome from bench to bedside: recent advances [version 1; referees: 2 approved]

Rett Syndrome is a severe neurological disorder mainly due to de novo mutations in the methyl-CpG-binding protein 2 gene (MECP2). Mecp2 is known to play a role in chromatin organization and transcriptional regulation. In this review, we report the latest advances on the molecular function of Mecp2 a...

Full description

Bibliographic Details
Main Authors: Yann Ehinger, Valerie Matagne, Laurent Villard, Jean-Christophe Roux
Format: Article
Language:English
Published: F1000 Research Ltd 2018-03-01
Series:F1000Research
Online Access:https://f1000research.com/articles/7-398/v1
_version_ 1811336963655991296
author Yann Ehinger
Valerie Matagne
Laurent Villard
Jean-Christophe Roux
author_facet Yann Ehinger
Valerie Matagne
Laurent Villard
Jean-Christophe Roux
author_sort Yann Ehinger
collection DOAJ
description Rett Syndrome is a severe neurological disorder mainly due to de novo mutations in the methyl-CpG-binding protein 2 gene (MECP2). Mecp2 is known to play a role in chromatin organization and transcriptional regulation. In this review, we report the latest advances on the molecular function of Mecp2 and the new animal and cellular models developed to better study Rett syndrome. Finally, we present the latest innovative therapeutic approaches, ranging from classical pharmacology to correct symptoms to more innovative approaches intended to cure the pathology.
first_indexed 2024-04-13T17:47:12Z
format Article
id doaj.art-a9f917d68e484636aa0742da47c40466
institution Directory Open Access Journal
issn 2046-1402
language English
last_indexed 2024-04-13T17:47:12Z
publishDate 2018-03-01
publisher F1000 Research Ltd
record_format Article
series F1000Research
spelling doaj.art-a9f917d68e484636aa0742da47c404662022-12-22T02:36:53ZengF1000 Research LtdF1000Research2046-14022018-03-01710.12688/f1000research.14056.115289Rett syndrome from bench to bedside: recent advances [version 1; referees: 2 approved]Yann Ehinger0Valerie Matagne1Laurent Villard2Jean-Christophe Roux3Aix Marseille Univ, INSERM, MMG, 13385 Marseille, FranceAix Marseille Univ, INSERM, MMG, 13385 Marseille, FranceAix Marseille Univ, INSERM, MMG, 13385 Marseille, FranceAix Marseille Univ, INSERM, MMG, 13385 Marseille, FranceRett Syndrome is a severe neurological disorder mainly due to de novo mutations in the methyl-CpG-binding protein 2 gene (MECP2). Mecp2 is known to play a role in chromatin organization and transcriptional regulation. In this review, we report the latest advances on the molecular function of Mecp2 and the new animal and cellular models developed to better study Rett syndrome. Finally, we present the latest innovative therapeutic approaches, ranging from classical pharmacology to correct symptoms to more innovative approaches intended to cure the pathology.https://f1000research.com/articles/7-398/v1
spellingShingle Yann Ehinger
Valerie Matagne
Laurent Villard
Jean-Christophe Roux
Rett syndrome from bench to bedside: recent advances [version 1; referees: 2 approved]
F1000Research
title Rett syndrome from bench to bedside: recent advances [version 1; referees: 2 approved]
title_full Rett syndrome from bench to bedside: recent advances [version 1; referees: 2 approved]
title_fullStr Rett syndrome from bench to bedside: recent advances [version 1; referees: 2 approved]
title_full_unstemmed Rett syndrome from bench to bedside: recent advances [version 1; referees: 2 approved]
title_short Rett syndrome from bench to bedside: recent advances [version 1; referees: 2 approved]
title_sort rett syndrome from bench to bedside recent advances version 1 referees 2 approved
url https://f1000research.com/articles/7-398/v1
work_keys_str_mv AT yannehinger rettsyndromefrombenchtobedsiderecentadvancesversion1referees2approved
AT valeriematagne rettsyndromefrombenchtobedsiderecentadvancesversion1referees2approved
AT laurentvillard rettsyndromefrombenchtobedsiderecentadvancesversion1referees2approved
AT jeanchristopheroux rettsyndromefrombenchtobedsiderecentadvancesversion1referees2approved